NASDAQ:GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Upgrade from BMO Capital

Font: Financial Modeling Prep  • Nov 24, 2025

Market Chart

Gilead Sciences, Inc. (NASDAQ:GILD) is a leading biopharmaceutical company renowned for its groundbreaking treatments in areas such as HIV, liver diseases, and cancer. BMO Capital recently upgraded its rating for GILD to "Outperform," signaling strong confidence in the company's future performance. At the time of this announcement, GILD was trading at $125.27.

The upgrade by BMO Capital is primarily attributed to the exceptional performance of Gilead's HIV division. The company's third-quarter results exceeded analyst expectations, largely due to the success of key products like Biktarvy and the newly launched Yeztugo. These products are anticipated to continue propelling growth, with no significant patent expirations expected until 2036.

Although there is currently a perceived weakness in the oncology and immunology segments, Gilead is actively taking strategic steps to bolster its pipeline. The company's recent mergers and acquisitions, including the acquisition of CymaBay, and the appointment of a new Chief Medical Officer with expertise in oncology, are aimed at enhancing these areas.

GILD's stock price has seen a slight decrease of 1.08%, or $1.37, with today's trading fluctuating between $124.49 and $128.25. Over the past year, the stock reached a high of $128.70 and a low of $88.57. With a market capitalization of approximately $155.42 billion, Gilead continues to be a major force in the biopharmaceutical sector.

Today's trading volume for GILD stands at 8,497,058 shares, showcasing active investor interest. As Gilead focuses on leveraging its strengths and addressing its challenges, the company's strategic initiatives are expected to further impact its stock performance moving forward.

Market Overview
NVDA
NVIDIA Corporation
$150.96
-2.89%
LICN
Lichen International Limited
$0.02
-29.55%
CHSN
Chanson International Holding
$0.10
-78.30%
SOXL
Direxion Daily Semiconductor Bull 3X ETF
$49.26
0.39%
SVRE
SaverOne 2014 Ltd
$0.86
111.01%
SPDN
Direxion Daily S&P 500 Bear 1X ETF
$8.90
0.34%
AKAN
Akanda Corp.
$4.03
96.59%
INLF
INLIF Limited
$0.23
-36.81%
AES
The AES Corporation
$15.02
0.33%
GRAB
Grab Holdings Limited
$3.14
-1.26%